MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 8 (2011), Issue 5 (May)

1. Splenic abscess caused by MRSA developing in an infarcted area: case report and literature review.
   J Infect Chemother. [Abstract] [Full-text]
2. Twenty years of countermeasures against postoperative methicillin-resistant Staphylococcus aureus infections.
   Surg Today, 41(5): 630-6. [Abstract] [Full-text]
3. Infection and colonization with methicillin resistant Staphylococcus aureus ST398 versus other MRSA in an area with a high density of pig farms.
   Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
4. Methicillin-Susceptible Staphylococcus aureus as a Predominantly Healthcare-Associated Pathogen: A Possible Reversal of Roles?
   PLoS One, 6(4): e18217. [Abstract] [Full-text]
5. Molecular Epidemiologic Analysis of Methicillin-Resistant Staphylococcus aureus Isolates from Bacteremia and Nasal Colonization at 10 Intensive Care Units: Multicenter Prospective Study in Korea.
   J Korean Med Sci, 26(5): 604-11. [Abstract] [Full-text]
6. Does linezolid modulate lung innate immunity in a murine model of methicillin-resistant Staphylococcus aureus pneumonia?
   Crit Care Med. [Abstract] [Full-text]
7. Hospital adoption of automated surveillance technology and the implementation of infection prevention and control programs.
   Am J Infect Control, 39(4): 270-6. [Abstract] [Full-text]
8. Activity of a dry mist-generated hydrogen peroxide disinfection system against methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii.
   Am J Infect Control. [Abstract] [Full-text]
9. Clinical issues-may 2011.
   AORN J, 93(5): 619-27. [Abstract] [Full-text]
10. Synthesis and in vitro antimicrobial activities of new (cyano-NNO-azoxy)pyrazole derivatives.
    Bioorg Med Chem Lett. [Abstract] [Full-text]
11. Prevalence and characterization of methicillin-resistant Staphylococcus aureus among healthy children in a city of Argentina.
    Infect Genet Evol. [Abstract] [Full-text]
12. Forced-air warming blowers: An evaluation of filtration adequacy and airborne contamination emissions in the operating room.
    Am J Infect Control, 39(4): 321-8. [Abstract] [Full-text]
13. "Somebody else's problem?" Staff perceptions of the sources and control of meticillin-resistant Staphylococcus aureus.
    Am J Infect Control, 39(4): 284-91. [Abstract] [Full-text]
14. Twenty years of countermeasures against postoperative methicillin-resistant Staphylococcus aureus infections.
    Surg Today, 41(5): 630-6. [Abstract] [Full-text]
15. Methicillin-susceptible Staphylococcus aureus as a predominantly healthcare-associated pathogen: a possible reversal of roles?
    PLoS One, 6(4): e18217. [Abstract] [Full-text]
16. Molecular epidemiologic analysis of methicillin-resistant Staphylococcus aureus isolates from bacteremia and nasal colonization at 10 intensive care units: multicenter prospective study in Korea.
    J Korean Med Sci, 26(5): 604-11. [Abstract] [Full-text]
17. Fat embolism syndrome after femur fracture with intramedullary nailing: case report.
    Am J Crit Care, 20(3): 267, 264-6. [Abstract] [Full-text]
18. Hospital adoption of automated surveillance technology and the implementation of infection prevention and control programs.
    Am J Infect Control, 39(4): 270-6. [Abstract] [Full-text]
19. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives.
    Eur J Med Chem, 46(6): 2421-6. [Abstract] [Full-text]
20. A modified CDC biofilm reactor to produce mature biofilms on the surface of peek membranes for an in vivo animal model application.
    Curr Microbiol, 62(6): 1657-63. [Abstract] [Full-text]
21. Forced-air warming blowers: An evaluation of filtration adequacy and airborne contamination emissions in the operating room.
    Am J Infect Control, 39(4): 321-8. [Abstract] [Full-text]
22. "Somebody else's problem?" Staff perceptions of the sources and control of meticillin-resistant Staphylococcus aureus.
    Am J Infect Control, 39(4): 284-91. [Abstract] [Full-text]
23. Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: An Analysis of the SIMPLIFI Trial.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
24. Fate of mutation rate depends on agr-locus expression during oxacillin-mediated Heterogeneous-Homogeneous selection in MRSA clinical strains.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
25. Enhancement of neutrophil function by IL-18 therapy protects burn-injured mice from MRSA infection.
    Infect Immun. [Abstract] [Full-text]
26. Quercetin Diacylglycoside Analogues Showing Dual Inhibition of DNA Gyrase and Topoisomerase IV as Novel Antibacterial Agents.
    J Med Chem. [Abstract] [Full-text]
27. Indicator microbes correlate with pathogenic bacteria, yeasts and helminthes in sand at a subtropical recreational beach site.
    J Appl Microbiol. [Abstract] [Full-text]
28. Potential Associations between Severity of Infection and the Presence of Virulence-Associated Genes in Clinical Strains of Staphylococcus aureus.
    PLoS One, 6(4): e18673. [Abstract] [Full-text]
29. Identification of a haemolysin-like peptide with antibacterial activity using the draft genome sequence of S. epidermidis strain A487.
    FEMS Immunol Med Microbiol. [Abstract] [Full-text]
30. Linezolid vs Glycopeptide Antibiotics for the Treatment of Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Meta-analysis of Randomized Controlled Trials.
    Chest, 139(5): 1148-55. [Abstract] [Full-text]
31. Potential associations between severity of infection and the presence of virulence-associated genes in clinical strains of Staphylococcus aureus.
    PLoS One, 6(4): e18673. [Abstract] [Full-text]
32. Developing a mouse model of acute bacterial rhinosinusitis.
    Eur Arch Otorhinolaryngol, 268(6): 857-61. [Abstract] [Full-text]
33. Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials.
    Chest, 139(5): 1148-55. [Abstract] [Full-text]
34. Rectovaginal Staphylococcus aureus Colonization: Is it a Neonatal Threat?
    Am J Perinatol. [Abstract] [Full-text]
35. Infection prevention and control in cystic fibrosis.
    Curr Opin Infect Dis. [Abstract] [Full-text]
36. Selenophene-Containing Inhibitors of Type IIA Bacterial Topoisomerases.
    J Med Chem, 54(9): 3418-25. [Abstract] [Full-text]
37. Exploration of the Activity of 7-Pyrrolidino-8-methoxyisothiazoloquinolones against Methicillin-Resistant Staphylococcus aureus (MRSA).
    J Med Chem, 54(9): 3268-82. [Abstract] [Full-text]
38. Selenophene-containing inhibitors of type IIA bacterial topoisomerases.
    J Med Chem, 54(9): 3418-25. [Abstract] [Full-text]
39. Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA).
    J Med Chem, 54(9): 3268-82. [Abstract] [Full-text]
40. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
    Diagn Microbiol Infect Dis. [Abstract] [Full-text]
41. Effectiveness of a novel ozone-based system for the rapid high-level disinfection of health care spaces and surfaces.
    Am J Infect Control. [Abstract] [Full-text]
42. Antibiotic resistance and molecular epidemiology of Staphylococcus aureus in Nigeria.
    BMC Microbiol, 11(1): 92. [Abstract] [Full-text]
43. Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: Comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia.
    Respirology. [Abstract] [Full-text]
44. Prevalence of Nasal Staphylococcus aureus Carriage in the Patients Undergoing Hemodialysis and Evaluation of Risk Factors and Laboratory Parameters.
    Ren Fail. [Abstract] [Full-text]
45. Prospective, non-comparative study of daptomycin for the treatment of superficial and deep incisional surgical site infections.
    Surg Infect (Larchmt), 12(2): 113-8. [Abstract] [Full-text]
46. Experimental Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus Treated with a Polylactide Carrier Releasing Linezolid.
    Surg Infect (Larchmt), 12(2): 131-5. [Abstract] [Full-text]
47. Efforts to support the development of fusidic acid in the United States.
    Clin Infect Dis, 52: S542-6. [Abstract] [Full-text]
48. Case report: treatment of chronic osteomyelitis.
    Clin Infect Dis, 52: S538-41. [Abstract] [Full-text]
49. The safety record of fusidic acid in non-US markets: a focus on skin infections.
    Clin Infect Dis, 52: S527-37. [Abstract] [Full-text]
50. A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.
    Clin Infect Dis, 52: S520-6. [Abstract] [Full-text]
51. Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dosing regimen: raising Lazarus from the dead.
    Clin Infect Dis, 52: S513-9. [Abstract] [Full-text]
52. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
    Clin Infect Dis, 52: S493-503. [Abstract] [Full-text]
53. In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States.
    Clin Infect Dis, 52: S477-86. [Abstract] [Full-text]
54. New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the good.
    Clin Infect Dis, 52: S469-76. [Abstract] [Full-text]
55. Adapting spa typing for national laboratory-based surveillance of methicillin-resistant Staphylococcus aureus.
    Eur J Clin Microbiol Infect Dis, 30(6): 789-97. [Abstract] [Full-text]
56. Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
    Bioorg Med Chem, 19(10): 3204-15. [Abstract] [Full-text]
57. Structural basis for ligand recognition and discrimination of a quorum-quenching antibody.
    J Biol Chem, 286(19): 17351-8. [Abstract] [Full-text]
58. Development of a bioactive fiber with immobilized synthetic peptides designed from the active site of a beetle defensin.
    Biomacromolecules, 12(5): 1540-5. [Abstract] [Full-text]
59. Epidemiology and risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus among burn patients.
    J Burn Care Res, 32(3): 429-34. [Abstract] [Full-text]
60. Pharmacokinetics and pharmacodynamics of intravenous daptomycin during continuous ambulatory peritoneal dialysis.
    Clin J Am Soc Nephrol, 6(5): 1081-8. [Abstract] [Full-text]
61. Vulnerability of an equine pericardial roll graft to Gram-positive cocci after graft replacement for a ruptured infected abdominal aorta.
    Interact Cardiovasc Thorac Surg, 12(5): 866-8. [Abstract] [Full-text]
62. Hospital staff perceptions of a legislative mandate for methicillin-resistant Staphylococcus aureus screening.
    Infect Control Hosp Epidemiol, 32(6): 573-8. [Abstract] [Full-text]
63. Modeling the spread of methicillin-resistant Staphylococcus aureus (MRSA) outbreaks throughout the hospitals in Orange County, California.
    Infect Control Hosp Epidemiol, 32(6): 562-72. [Abstract] [Full-text]
64. The antimicrobial efficacy of a silver alginate dressing against a broad spectrum of clinically relevant wound isolates.
    Int Wound J, 8(3): 237-43. [Abstract] [Full-text]
65. Anti-biofilm efficacy of a lactoferrin/xylitol wound hydrogel used in combination with silver wound dressings.
    Int Wound J, 8(3): 268-73. [Abstract] [Full-text]
66. Quantification of methicillin-resistant Staphylococcus aureus strains in marine and freshwater samples by the most-probable-number method.
    Appl Environ Microbiol, 77(10): 3541-3. [Abstract] [Full-text]
67. Methicillin-resistant Staphylococcus aureus (MRSA) in three dairy herds in southwest Germany.
    Zoonoses Public Health, 58(4): 252-61. [Abstract] [Full-text]
68. Longitudinal investigation of methicillin-resistant Staphylococcus aureus in piglets.
    Zoonoses Public Health, 58(4): 238-43. [Abstract] [Full-text]
69. Identification of a tetraene-containing product of the indanomycin biosynthetic pathway.
    Org Lett, 13(10): 2536-9. [Abstract] [Full-text]
70. Molecular characterization of spa type t127, sequence type 1 methicillin-resistant Staphylococcus aureus from pigs.
    J Antimicrob Chemother, 66(6): 1231-5. [Abstract] [Full-text]
71. Characterization of Methicillin-resistant Staphylococcus aureus isolated from public surfaces on a university campus, student homes and local community.
    J Appl Microbiol, 110(6): 1531-7. [Abstract] [Full-text]
72. Indicator microbes correlate with pathogenic bacteria, yeasts and helminthes in sand at a subtropical recreational beach site.
    J Appl Microbiol, 110(6): 1571-83. [Abstract] [Full-text]
73. Molecular basis of rifampicin resistance in methicillin-resistant Staphylococcus pseudintermedius isolates from dogs.
    J Antimicrob Chemother, 66(6): 1236-42. [Abstract] [Full-text]
74. Diversity and antimicrobial activity of Pseudovibrio spp. from Irish marine sponges.
    J Appl Microbiol, 110(6): 1495-508. [Abstract] [Full-text]
75. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model.
    J Antimicrob Chemother, 66(6): 1301-5. [Abstract] [Full-text]
76. Damage of staphylococcal cytoplasmic membrane by Quercus infectoria G. Olivier and its components.
    Lett Appl Microbiol, 52(6): 565-72. [Abstract] [Full-text]
77. Needle aspiration for the etiologic diagnosis of children with cellulitis in the era of community-acquired methicillin-resistant Staphylococcus aureus.
    Clin Pediatr (Phila), 50(6): 503-7. [Abstract] [Full-text]
78. Treatment considerations for recurrent MRSA bacteremia leading to cholecystitis.
    J Gen Intern Med, 26(6): 669-72. [Abstract] [Full-text]
79. New noncovalent inhibitors of penicillin-binding proteins from penicillin-resistant bacteria.
    PLoS One, 6(5): e19418. [Abstract] [Full-text]
80. Population structure of Staphylococcus aureus from remote African Babongo Pygmies.
    PLoS Negl Trop Dis, 5(5): e1150. [Abstract] [Full-text]
81. Zinc resistance of Staphylococcus aureus of animal origin is strongly associated with methicillin resistance.
    Vet Microbiol, 150(3): 344-8. [Abstract] [Full-text]
82. Microarray-based genotyping of Staphylococcus aureus isolates from camels.
    Vet Microbiol, 150(3): 309-14. [Abstract] [Full-text]
83. The microbiology of secondary and postoperative pancreatic infections: implications for antimicrobial management.
    Arch Surg, 146(5): 613-9. [Abstract] [Full-text]
84. Prevalence of nasal Staphylococcus aureus carriage in the patients undergoing hemodialysis and evaluation of risk factors and laboratory parameters.
    Ren Fail, 33(5): 494-8. [Abstract] [Full-text]
85. Epidemiology and virulence insights from MRSA and MSSA genome analysis.
    Future Microbiol, 6(5): 513-32. [Abstract] [Full-text]
86. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
    J Hosp Infect, 78(2): 102-7. [Abstract] [Full-text]
87. Prevalence of antiseptic-resistance genes in Staphylococcus aureus and coagulase-negative staphylococci colonising nurses and the general population in Hong Kong.
    J Hosp Infect, 78(2): 113-7. [Abstract] [Full-text]
88. Review of a three-year meticillin-resistant Staphylococcus aureus screening programme.
    J Hosp Infect, 78(2): 81-5. [Abstract] [Full-text]
89. Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis.
    J Hosp Infect, 78(2): 118-22. [Abstract] [Full-text]
90. Prevalence and molecular epidemiology of meticillin-resistant Staphylococcus aureus in nursing home residents in northern Germany.
    J Hosp Infect, 78(2): 108-12. [Abstract] [Full-text]
91. Multistate modelling to estimate the excess length of stay associated with meticillin-resistant Staphylococcus aureus colonisation and infection in surgical patients.
    J Hosp Infect, 78(2): 86-91. [Abstract] [Full-text]
92. Pre-emptive contact precautions for intubated patients reduced healthcare-associated meticillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit.
    J Hosp Infect, 78(2): 97-101. [Abstract] [Full-text]
93. Role of overcrowding in meticillin-resistant Staphylococcus aureus transmission: Bayesian network analysis for a single public hospital.
    J Hosp Infect, 78(2): 92-6. [Abstract] [Full-text]
94. Treatment intensity and characteristics of MRSA infection in CF.
    J Cyst Fibros, 10(3): 201-6. [Abstract] [Full-text]
95. Colonization and transmission of meticillin-susceptible and meticillin-resistant Staphylococcus aureus in a murine nasal colonization model.
    J Med Microbiol, 60: 812-6. [Abstract] [Full-text]
96. Culture-negative osteoarticular infections in the era of community-associated methicillin-resistant Staphylococcus aureus.
    Pediatr Infect Dis J, 30(6): 523-5. [Abstract] [Full-text]
97. Treatment of the severely infected frontal sinus with latissimus dorsi myocutaneous free flaps.
    J Craniofac Surg, 22(3): 962-6. [Abstract] [Full-text]
98. A family of multicyclic indolosesquiterpenes from a bacterial endophyte.
    Org Biomol Chem, 9(11): 4029-31. [Abstract] [Full-text]
99. In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens.
    Antimicrob Agents Chemother, 55(6): 2860-71. [Abstract] [Full-text]
100. Prospective, open-label investigation of the pharmacokinetics of daptomycin during cardiopulmonary bypass surgery.
     Antimicrob Agents Chemother, 55(6): 2499-505. [Abstract] [Full-text]
101. Novel types of staphylococcal cassette chromosome mec elements identified in clonal complex 398 methicillin-resistant Staphylococcus aureus strains.
     Antimicrob Agents Chemother, 55(6): 3046-50. [Abstract] [Full-text]
102. Distribution of antiseptic resistance genes qacA, qacB, and smr in methicillin-resistant Staphylococcus aureus isolated in Toronto, Canada, from 2005 to 2009.
     Antimicrob Agents Chemother, 55(6): 2999-3001. [Abstract] [Full-text]
103. In vitro activity of ceftaroline against gram-positive and gram-negative pathogens isolated from patients in Canadian hospitals in 2009.
     Antimicrob Agents Chemother, 55(6): 2837-46. [Abstract] [Full-text]
104. Microtiter plate-based assay for inhibitors of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus.
     Antimicrob Agents Chemother, 55(6): 2783-7. [Abstract] [Full-text]
105. Improved oxacillin treatment outcomes in experimental skin and lung infection by a methicillin-resistant Staphylococcus aureus isolate with a vraSR operon deletion.
     Antimicrob Agents Chemother, 55(6): 2818-23. [Abstract] [Full-text]
106. Acute necrotic stomatitis (noma) associated with methicillin-resistant Staphylococcus aureus infection in a newly acquired rhesus macaque (Macaca mulatta).
     J Med Primatol, 40(3): 188-93. [Abstract] [Full-text]
107. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application.
     J Cataract Refract Surg, 37(6): 1082-9. [Abstract] [Full-text]
108. In vitro activity of tigecycline against extended-spectrum β-lactamase-producing Enterobacteriaceae and MRSA clinical isolates from Mexico: a multicentric study.
     Diagn Microbiol Infect Dis, 70(2): 270-3. [Abstract] [Full-text]
109. First identification of methicillin-resistant Staphylococcus aureus MLST types ST5 and ST45 and SCCmec types IV and Vt by multiplex PCR during an outbreak in a respiratory care ward in central Taiwan.
     Diagn Microbiol Infect Dis, 70(2): 175-82. [Abstract] [Full-text]
110. Rapid identification of community-associated methicillin-resistant Staphylococcus aureus by Fourier transform infrared spectroscopy.
     Diagn Microbiol Infect Dis, 70(2): 157-66. [Abstract] [Full-text]
111. Colonization with community-acquired methicillin-resistant Staphylococcus aureus in children with atopic dermatitis: a cross-sectional study.
     Int J Dermatol, 50(6): 682-8. [Abstract] [Full-text]
112. Methicillin-resistant Staphylococcus aureus in a population of horses in Australia.
     Aust Vet J, 89(6): 221-5. [Abstract] [Full-text]
113. Synthesis and in vitro antimicrobial activities of new (cyano-NNO-azoxy)pyrazole derivatives.
     Bioorg Med Chem Lett, 21(11): 3431-4. [Abstract] [Full-text]
114. ABC transporters required for export of wall teichoic acids do not discriminate between different main chain polymers.
     ACS Chem Biol, 6(5): 407-12. [Abstract] [Full-text]
115. The SaeR/S gene regulatory system induces a pro-inflammatory cytokine response during Staphylococcus aureus infection.
     PLoS One, 6(5): e19939. [Abstract] [Full-text]
116. Refinement of a simple technique with new relevance for exsanguination of the upper limb.
     Tech Hand Up Extrem Surg, 15(2): 82-3. [Abstract] [Full-text]
117. Total synthesis and biological evaluation of marinopyrrole A and analogues.
     Tetrahedron Lett, 52(17): 2041-2043. [Abstract] [Full-text]
118. Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods.
     Nanotoxicology, 5(2): 244-53. [Abstract] [Full-text]
119. Synthesis, characterization, and antimicrobial evaluation of oxadiazole congeners.
     Molecules, 16(6): 4339-47. [Abstract] [Full-text]
120. Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion.
     Microb Drug Resist, 17(2): 321-8. [Abstract] [Full-text]
121. Molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus in Hokkaido, northern main island of Japan: identification of sequence types 6 and 59 Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus.
     Microb Drug Resist, 17(2): 241-50. [Abstract] [Full-text]
122. Analysis of Staphylococcal cassette chromosome mec in Staphylococcus haemolyticus and Staphylococcus sciuri: identification of a novel ccr gene complex with a newly identified ccrA allotype (ccrA7).
     Microb Drug Resist, 17(2): 291-7. [Abstract] [Full-text]
123. Molecular detection and characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates from dogs in Portugal.
     Microb Drug Resist, 17(2): 333-7. [Abstract] [Full-text]
124. Increasing resistance in multiresistant methicillin-resistant Staphylococcus aureus clones isolated from a Chinese hospital over a 5-year period.
     Microb Drug Resist, 17(2): 235-9. [Abstract] [Full-text]
125. Performance of the BD GeneOhm MRSA achromopeptidase assay for real-time PCR detection of methicillin-resistant Staphylococcus aureus in nasal specimens.
     J Clin Microbiol, 49(6): 2266-8. [Abstract] [Full-text]
126. Evidence for a purifying selection acting on the β-lactamase locus in epidemic clones of methicillin-resistant Staphylococcus aureus.
     BMC Microbiol, 11: 76. [Abstract] [Full-text]
127. Detection of intermediately vancomycin-susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and Agar screening methods.
     J Clin Microbiol, 49(6): 2147-50. [Abstract] [Full-text]
128. Rapid differentiation of methicillin-resistant and methicillin-susceptible Staphylococcus aureus by flow cytometry after brief antibiotic exposure.
     J Clin Microbiol, 49(6): 2116-20. [Abstract] [Full-text]
129. Determination of vancomycin and daptomycin MICs by different testing methods for methicillin-resistant Staphylococcus aureus.
     J Clin Microbiol, 49(6): 2272-3. [Abstract] [Full-text]
130. A new anti-MRSA antibiotic complex, WAP-8294A II. Structure characterization of minor components by ESI LCMS and MS/MS.
     J Antibiot (Tokyo), 64(5): 373-9. [Abstract] [Full-text]
131. Ventilator-associated pneumonia in critically ill stroke patients: frequency, risk factors, and outcomes.
     J Crit Care, 26(3): 273-9. [Abstract] [Full-text]
132. A new drimane sesquiterpenoid glycoside from the seeds of Antiaris toxicaria.
     J Asian Nat Prod Res, 13(6): 561-5. [Abstract] [Full-text]
133. Airway pathogens during the first year after lung transplantation: a single-center experience.
     Transplant Proc, 43(4): 1290-1. [Abstract] [Full-text]
134. Chemical constituents from endophytic fungus Fusarium oxysporum.
     Fitoterapia, 82(5): 777-81. [Abstract] [Full-text]
135. Prevalence and characterization of methicillin-resistant Staphylococcus aureus among healthy children in a city of Argentina.
     Infect Genet Evol, 11(5): 1066-71. [Abstract] [Full-text]
136. Sequence diversities of serine-aspartate repeat genes among Staphylococcus aureus isolates from different hosts presumably by horizontal gene transfer.
     PLoS One, 6(5): e20332. [Abstract] [Full-text]
137. Do mobile phones of patients, companions and visitors carry multidrug-resistant hospital pathogens?
     Am J Infect Control, 39(5): 379-81. [Abstract] [Full-text]
138. An integrative review of infection prevention and control programs for multidrug-resistant organisms in acute care hospitals: a socio-ecological perspective.
     Am J Infect Control, 39(5): 368-78. [Abstract] [Full-text]
139. Isolation and characterization of methicillin-resistant Staphylococcus aureus from fire stations in two northwest fire districts.
     Am J Infect Control, 39(5): 382-9. [Abstract] [Full-text]
140. Successful management of an MRSA outbreak in a neonatal intensive care unit.
     Eur J Clin Microbiol Infect Dis, 30(7): 909-13. [Abstract] [Full-text]
141. A theoretical analysis of the prodrug delivery system for treating antibiotic-resistant bacteria.
     IEEE/ACM Trans Comput Biol Bioinform, 8(3): 650-8. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.